PDS Biotech Announces Expanded Interim Data in PDS0101 Triple Combination Phase 2 Trial Targeting Advanced HPV-Positive CancersGlobeNewsWire • 10/11/22
PDS Biotech Announces Successful End-of-Phase 2 Meeting With the FDA and Preparation for the Registrational Trial of PDS0101 in Combination With KEYTRUDA®GlobeNewsWire • 10/03/22
PDS Biotech to Participate at Cantor Fitzgerald's Oncology & HemOnc ConferenceGlobeNewsWire • 09/22/22
PDS Biotech and National Cancer Institute Identify Optimal Patient Group for Advancing PDS0101-Based Triple Combination Program Targeting Advanced HPV-Positive CancersGlobeNewsWire • 09/21/22
PDS Biotech Completes $35 Million Financing Agreement Led By Horizon Technology FinanceGlobeNewsWire • 08/24/22
How Much Upside is Left in PDS Biotechnology (PDSB)? Wall Street Analysts Think 265%Zacks Investment Research • 08/11/22
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/08/22
PDS Biotech Reports Second Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 08/08/22
PDS Biotech Independent Data Monitoring Committee Recommends VERSATILE-002 Trial Continuation without ModificationsGlobeNewsWire • 08/04/22
PDS Biotechnology Announces Presentation of Universal Flu Vaccine Preclinical Data at the 41st American Society of Virology MeetingGlobeNewsWire • 07/14/22
PDS Biotechnology Appoints Spencer Brown as Senior Vice President, General CounselGlobeNewsWire • 06/03/22
PDS Biotech Announces Presentation of Efficacy and Safety Data from VERSATILE-002 Phase 2 Clinical Trial in Recurrent or Metastatic Head and Neck Cancer at ASCO 2022GlobeNewsWire • 05/26/22
PDS Biotech Announces Presentation of Data from NCI-Led Triple Combination Phase 2 Clinical Trial in Advanced, Refractory HPV-Positive Cancers at ASCO 2022GlobeNewsWire • 05/26/22
NetSceintific highlights PDS Biotech's key posters at upcoming ASCO conferenceProactive Investors • 05/11/22
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/11/22
PDS Biotech Provides Business Update and Reports First Quarter 2022 Financial ResultsGlobeNewsWire • 05/11/22
PDS Biotech Announces Two Abstracts Accepted for Presentation at the 2022 American Society of Clinical Oncology Annual MeetingGlobeNewsWire • 04/27/22
PDS Biotechnology Corporation (PDSB) CEO Frank Bedu-Addo on Q4 2021 Results - Earnings Call TranscriptSeeking Alpha • 03/31/22